Veravas appoints new members to its advisory Board
Veravas, Inc., an emerging diagnostic company, appointed eight members to its Advisory Board
Pharmaceuticals, Biotechnology and Life Sciences
Veravas, Inc., an emerging diagnostic company, appointed eight members to its Advisory Board
DUBLIN–(BUSINESS WIRE)–The “Fotivda” report has been added to ResearchAndMarkets.com’s offering. Fotivda (tivozanib; AVEO Oncology/EUSA Pharma/Kyowa Hakko Kirin) is an oral…
Acceleron has completed target enrollment of patients with pulmonary arterial hypertension (PAH) in the PULSAR Phase 2 trial of sotatercept
National reimbursement decision for Optune® in Germany anticipated in 2020 ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) today announced that the…
Faron Pharmaceuticals’s CEO Markku Jalk said it was disappointing to learn about the magnitude of steroid use in the patient population as RAAA is considered as a traumatic condition and to have only limited inflammatory impact on disease development.
Zealand Pharma has dosed the first out of 64 healthy patients, in a Phase 1 clinical test of ZP7570 as a potential first-in-class next generation treatment of short bowel syndrome (SBS).
Phase 1/2 clinical trial to evaluate Intensity’s INT230-6 in combination with KEYTRUDA® (pembrolizumab) for multiple solid tumor types
Contrad Swiss, a pharmaceutical company focused on breakthrough, innovative products that reframe the world of medicine, announces a new partnership with Dr JO Serrentino.
Leading South Korean biopharmaceutical modernizes trial operations to maintain inspection readiness and have a comprehensive view of study status PLEASANTON,…
BOSTON–(BUSINESS WIRE)–Decibel Therapeutics, a clinical-stage biotechnology company developing novel therapeutics for hearing loss and balance disorders, today announced the appointment…